Literature DB >> 22095730

Dominant-negative control of cAMP-dependent IKs upregulation in human long-QT syndrome type 1.

Jordi Heijman1, Roel L H M G Spätjens, Sandrine R M Seyen, Viola Lentink, Helma J H Kuijpers, Inge R Boulet, Leon J de Windt, Miren David, Paul G A Volders.   

Abstract

RATIONALE: The mutation A341V in the S6 transmembrane segment of KCNQ1, the α-subunit of the slowly activating delayed-rectifier K(+) (I(Ks)) channel, predisposes to a severe long-QT1 syndrome with sympathetic-triggered ventricular tachyarrhythmias and sudden cardiac death.
OBJECTIVE: Several genetic risk modifiers have been identified in A341V patients, but the molecular mechanisms underlying the pronounced repolarization phenotype, particularly during β-adrenergic receptor stimulation, remain unclear. We aimed to elucidate these mechanisms and provide new insights into control of cAMP-dependent modulation of I(Ks). METHODS AND
RESULTS: We characterized the effects of A341V on the I(Ks) macromolecular channel complex in transfected Chinese hamster ovary cells and found a dominant-negative suppression of cAMP-dependent Yotiao-mediated I(Ks) upregulation on top of a dominant-negative reduction in basal current. Phosphomimetic substitution of the N-terminal position S27 with aspartic acid rescued this loss of upregulation. Western blot analysis showed reduced phosphorylation of KCNQ1 at S27, even for heterozygous A341V, suggesting that phosphorylation defects in some (mutant) KCNQ1 subunits can completely suppress I(Ks) upregulation. Functional analyses of heterozygous KCNQ1 WT:G589D and heterozygous KCNQ1 WT:S27A, a phosphorylation-inert substitution, also showed such suppression. Immunoprecipitation of Yotiao with KCNQ1-A341V (in the presence of KCNE1) was not different from wild-type.
CONCLUSIONS: Our results indicate the involvement of the KCNQ1-S6 region at/or around A341 in cAMP-dependent stimulation of I(Ks), a process that is under strong dominant-negative control, suggesting that tetrameric KCNQ1 phosphorylation is required. Specific long-QT1 mutations, including heterozygous A341V, disable this regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095730     DOI: 10.1161/CIRCRESAHA.111.249482

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  28 in total

1.  High-Throughput Functional Evaluation of KCNQ1 Decrypts Variants of Unknown Significance.

Authors:  Carlos G Vanoye; Reshma R Desai; Katarina L Fabre; Shannon L Gallagher; Franck Potet; Jean-Marc DeKeyser; Daniela Macaya; Jens Meiler; Charles R Sanders; Alfred L George
Journal:  Circ Genom Precis Med       Date:  2018-11

Review 2.  Ion Channels in the Heart.

Authors:  Daniel C Bartos; Eleonora Grandi; Crystal M Ripplinger
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

3.  Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1.

Authors:  Alberto Porta; Giulia Girardengo; Vlasta Bari; Alfred L George; Paul A Brink; Althea Goosen; Lia Crotti; Peter J Schwartz
Journal:  J Am Coll Cardiol       Date:  2015-02-03       Impact factor: 24.094

4.  Enhanced effects of isoflurane on the long QT syndrome 1-associated A341V mutant.

Authors:  Ikuomi Mikuni; Carlos G Torres; Tania Bakshi; Akihito Tampo; Brian E Carlson; Martin W Bienengraeber; Wai-Meng Kwok
Journal:  Anesthesiology       Date:  2015-04       Impact factor: 7.892

Review 5.  Regulation of sarcoplasmic reticulum Ca2+ release by serine-threonine phosphatases in the heart.

Authors:  Dmitry Terentyev; Shanna Hamilton
Journal:  J Mol Cell Cardiol       Date:  2016-08-29       Impact factor: 5.000

6.  Quantitative analysis of the Ca2+ -dependent regulation of delayed rectifier K+ current IKs in rabbit ventricular myocytes.

Authors:  Daniel C Bartos; Stefano Morotti; Kenneth S Ginsburg; Eleonora Grandi; Donald M Bers
Journal:  J Physiol       Date:  2017-03-28       Impact factor: 5.182

Review 7.  Genetics of sudden cardiac death caused by ventricular arrhythmias.

Authors:  Roos F Marsman; Hanno L Tan; Connie R Bezzina
Journal:  Nat Rev Cardiol       Date:  2013-12-10       Impact factor: 32.419

8.  A KCNQ1 mutation causes a high penetrance for familial atrial fibrillation.

Authors:  Daniel C Bartos; Jeffrey B Anderson; Rachel Bastiaenen; Jonathan N Johnson; Michael H Gollob; David J Tester; Don E Burgess; Tessa Homfray; Elijah R Behr; Michael J Ackerman; Pascale Guicheney; Brian P Delisle
Journal:  J Cardiovasc Electrophysiol       Date:  2013-01-25

Review 9.  Impact of genetics on the clinical management of channelopathies.

Authors:  Peter J Schwartz; Michael J Ackerman; Alfred L George; Arthur A M Wilde
Journal:  J Am Coll Cardiol       Date:  2013-05-15       Impact factor: 24.094

10.  A KCNQ1 mutation contributes to the concealed type 1 long QT phenotype by limiting the Kv7.1 channel conformational changes associated with protein kinase A phosphorylation.

Authors:  Daniel C Bartos; John R Giudicessi; David J Tester; Michael J Ackerman; Seiko Ohno; Minoru Horie; Michael H Gollob; Don E Burgess; Brian P Delisle
Journal:  Heart Rhythm       Date:  2013-11-21       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.